{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&version=2", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&version=2", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&_metadata=all&version=2", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&version=2", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&version=2", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&version=2", "items" : [{"_about" : "http://data.parliament.uk/resources/229124", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229124/answer", "answerText" : {"_value" : "

The original contract for the Nottingham Treatment Centre was signed in July 2005 between the Secretary of State for Health, the local primary care trusts (PCTs) and Circle after approval of a business case for the scheme by the Department. The services provided by the Treatment Centre include dermatology. The Treatment Centre became operational in July 2008 after construction completion.<\/p>

<\/p>

<\/p>

<\/p>

The Department was not involved directly or indirectly in the reprocurement of the services. On 1 April 2013 the Department\u2019s responsibility under the contract passed to NHS England. The reprocurement was managed locally by the clinical commissioning group and the local area team of NHS England; the contract was awarded to Circle after a competitive procurement process.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T11:08:15.673Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Dermatology"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what his Department's (a) direct and (b) indirect involvement in (i) the procurement of dermatology services from Nottingham University Hospitals Trust to Circle in 2007 and (ii) the reprocurement of those services in 2012; and whether that involvement was in an advisory capacity.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4029", "label" : {"_value" : "Biography information for Lilian Greenwood"} } , "tablingMemberConstituency" : {"_value" : "Nottingham South"} , "tablingMemberPrinted" : [{"_value" : "Lilian Greenwood"} ], "uin" : "228787"} , {"_about" : "http://data.parliament.uk/resources/229132", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229132/answer", "answerText" : {"_value" : "

Information on spend for audiology services and specific procedures for hearing problems are not available in the format requested. The following table provides NHS programme budgeting figures on \u2018problems of hearing\u2019 for the five year period 2008-09 to 2012-13, which is the latest available data.<\/p>

<\/p>

<\/p>

<\/p>

Year<\/p><\/td>

2008-09<\/p><\/td>

2009-10<\/p><\/td>

2010-11<\/p><\/td>

2011-12<\/p><\/td>

2012-13<\/p><\/td><\/tr>

Expenditure (£ billion)<\/p><\/td>

0.42<\/p><\/td>

0.50<\/p><\/td>

0.45<\/p><\/td>

0.46<\/p><\/td>

0.46<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

<\/p>

<\/p>

More information about programme budgeting data can be found on the NHS England website at the following link:<\/p>

<\/p>

<\/p>

<\/p>

http://www.england.nhs.uk/resources/resources-for-ccgs/prog-budgeting/<\/a><\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "answeringMemberConstituency" : {"_value" : "North Norfolk"} , "answeringMemberPrinted" : {"_value" : "Norman Lamb"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "228771"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T13:04:11.037Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hearing Impairment"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, how much the NHS has spent on audiology services in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4268", "label" : {"_value" : "Biography information for Steve Reed"} } , "tablingMemberConstituency" : {"_value" : "Croydon North"} , "tablingMemberPrinted" : [{"_value" : "Mr Steve Reed"} ], "uin" : "228770"} , {"_about" : "http://data.parliament.uk/resources/229151", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229151/answer", "answerText" : {"_value" : "

<\/strong><\/p>

<\/p>

The National Institute for Health and Care Excellence (NICE) considered the suitability of ponatinib for the treatment of chronic myeloid leukaemia for referral to its technology appraisal work programme through the topic selection process in 2013-14. NICE concluded, following consultation with stakeholders, that a technology appraisal was not appropriate, noting that the likely eligible patient population was very small. Further information on the rationale for not referring this topic to NICE is available on the NICE website at:<\/p>

<\/p>

<\/p>

<\/p>

http://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/block-scoping-reports<\/a><\/p>

<\/p>

<\/p>

<\/p>

A number of treatments, including the drug bosutinib, are available through the Cancer Drugs Fund for patients with chronic myeloid leukaemia who are intolerant or resistant to other tyrosine-kinase inhibitor therapies.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "228645"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T11:23:31.313Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Leukaemia: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of NICE's decision not to appraise the drug ponatinib for chronic myeloid leukaemia; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1383", "label" : {"_value" : "Biography information for Mark Tami"} } , "tablingMemberConstituency" : {"_value" : "Alyn and Deeside"} , "tablingMemberPrinted" : [{"_value" : "Mark Tami"} ], "uin" : "228644"} , {"_about" : "http://data.parliament.uk/resources/229159", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229159/answer", "answerText" : {"_value" : "

The information the Human Fertilisation and Embryology Authority (HFEA) holds on number of incidents of hospitalisation due to ovarian hyperstimulation syndrome (OHSS), that have been reported to the Authority, is set out in the written answer provided to the then hon. Member for Heywood and Middleton on 24 June 2014, Official Report,<\/em> columns 156-157W (UIN 201565).<\/p>

<\/p>

<\/p>

<\/p>

The HFEA has advised that the responsibility for reporting adverse reactions in accordance with the Human Medicines Regulations 2012 rests with clinics and the treating clinician. Should the HFEA be made aware of information relevant to the regulatory functions of the Medicines and Healthcare products Regulatory Agency, this information would be shared between the two organisations.<\/p>

<\/p>

<\/p>

<\/p>

The Department is satisfied that the Authority is fulfilling its statutory duties as set out in the Human Fertilisation and Embryology Act 1990, as amended.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T11:28:01.6Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ovarian Hyperstimulation Syndrome"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, with reference to the Answers of 2 December 2014 to Question HL2907 and 17 March 2015 to Question HL5319 and the Written Statement of 24 November 2010, Official Report, columns WS101-2, on Questions for Written Answer: Correction, how many incidents of hospitalisation due to ovarian hyperstimulation syndrome (OHSS) have been reported to the Human Fertilisation and Embryology Authority (HFEA); what steps the HFEA takes to ensure that any suspected serious adverse reactions are reported to the licensing authority in accordance with the Human Medicines Regulations 2012; what steps the HFEA takes in cases of failure to report any such incidents to the Medicines and Healthcare Products Regulatory Agency; and whether he is satisfied that the HFEA is doing enough to protect patients from OHSS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "228699"} , {"_about" : "http://data.parliament.uk/resources/229166", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229166/answer", "answerText" : {"_value" : "

No patient communications will occur until the independent expert Dame Fiona Caldicott, as National Data Guardian, has reviewed them and provided advice.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T14:22:17.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Records: Databases"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, by what date he plans to start patient communications in care.data pathfinder areas on the implications for patients of that programme to begin.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/304", "label" : {"_value" : "Biography information for Mr Roger Godsiff"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Hall Green"} , "tablingMemberPrinted" : [{"_value" : "Mr Roger Godsiff"} ], "uin" : "228664"} , {"_about" : "http://data.parliament.uk/resources/229170", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229170/answer", "answerText" : {"_value" : "

Data on beds open overnight or day only is routinely collected and data since 2000-01 is published online at:<\/p>

<\/p>

<\/p>

<\/p>

http://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/<\/a><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T14:19:12.273Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hospital Beds: East Midlands"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, how many hospital beds in each sector or service there have been in (a) Sherwood Forest Hospitals and (b) Nottingham University Hospitals NHS Foundation Trusts in each year since 2008.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3915", "label" : {"_value" : "Biography information for Gloria De Piero"} } , "tablingMemberConstituency" : {"_value" : "Ashfield"} , "tablingMemberPrinted" : [{"_value" : "Gloria De Piero"} ], "uin" : "228754"} , {"_about" : "http://data.parliament.uk/resources/229176", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229176/answer", "answerText" : {"_value" : "

NHS England currently has no plans to ask the Department to consider making any changes in respect of those provisions of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, as amended, that relate to dispensing appliance contractors. If NHS England were to undertake a review of the regulatory arrangements concerning dispensing appliance contractors, it would take account of a range of factors including the views of patients, consumers and business.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "228746"} , {"_value" : "228747"} , {"_value" : "228748"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-26T14:22:34.77Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Equipment"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what part consultation and stakeholder engagement will play in NHS England's review of regulations relating to dispensing appliance contractor licences.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"} } , "tablingMemberConstituency" : {"_value" : "Knowsley"} , "tablingMemberPrinted" : [{"_value" : "Mr George Howarth"} ], "uin" : "228749"} , {"_about" : "http://data.parliament.uk/resources/229258", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/229258/answer", "answerText" : {"_value" : "

The Department funds research through the National Institute for Health Research (NIHR) and the Department\u2019s Policy Research Programme (PRP). The NIHR\u2019s policy statement on open access for its funded research can be found on the NIHR website:<\/p>

<\/p>

<\/p>

<\/p>

http://www.nihr.ac.uk/policy-and-standards/nihr-policy-on-open-access-for-its-funded-research.htm<\/a><\/p>

<\/p>

<\/p>

<\/p>

Details of commissioned and researcher-led projects funded through programmes managed by the NIHR Evaluation, Trials and Studies Coordinating Centre can be found on the centre\u2019s website:<\/p>

<\/p>

<\/p>

<\/p>

http://www.nets.nihr.ac.uk/projects?collection=netscc&meta_P_sand=Project<\/a><\/p>

<\/p>

<\/strong><\/p>

<\/p>

These details include research summary, contractor, cost, start date, estimated date of publication, and links to commissioning briefs and published reports.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

Details of projects, initiatives and long-term programmes of research currently funded by the PRP are available on the website of the PRP Central Commissioning Facility:<\/p>

<\/p>

<\/p>

<\/p>

http://www.prp-ccf.org.uk/<\/a><\/p>

<\/p>

<\/p>

<\/p>

These details include research summary, contractor, start date, and estimated date of completion. Cost will be included in future updates. The website also has links to summary final reports received since April 2011.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

<\/strong><\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-25T17:28:13.833Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what research reports his Department has commissioned from external bodies between September 2010 and December 2014 have not been published; when each such report was commissioned; what the nature of the research commissioned for each report was; from whom each such research report was commissioned; what the value of each such commission was; on what date each such report was received by his Department; for what reason each such research report has not yet been published; and when he plans to publish each such report.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/394", "label" : {"_value" : "Biography information for Mr Clive Betts"} } , "tablingMemberConstituency" : {"_value" : "Sheffield South East"} , "tablingMemberPrinted" : [{"_value" : "Mr Clive Betts"} ], "uin" : "228818"} , {"_about" : "http://data.parliament.uk/resources/228868", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/228868/answer", "answerText" : {"_value" : "

NHS England\u2019s process for developing interim commissioning policies involves evidence review, recommendation development, and service and financial impact assessment.<\/p>

<\/p>

<\/p>

<\/p>

NHS England\u2019s Clinical Reference Groups (CRGs), Public Health England and other stakeholders are involved in these processes.<\/p>

<\/p>

<\/p>

<\/p>

The recommendations of CRGs are considered by the relevant Programme of Care Board and then the Clinical Priorities Advisory Group (CPAG).<\/p>

<\/p>

<\/p>

<\/p>

The draft interim policy for treatment of hepatitis C in patients with cirrhosis is following this process. NHS England has advised that it will be considered by the Programme of Care Board at the end of March and then by CPAG.<\/p>

<\/p>

<\/p>

<\/p>

The financial impact assessment of the interim policy is continuing. This will inform the decision on financial planning that NHS England will take with regard to this policy.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-03-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-25T16:20:42.6Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hepatitis: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answers of 27 February 2015 to Questions 225235 and 225238, by what process NHS England is developing the interim commissioning policies referred to in those Answers; whether funding has been allocated to support those policies; and whether those policies have been discussed by the Clinical Priorities Advisory Group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "228635"} , {"_about" : "http://data.parliament.uk/resources/228571", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/228571/answer", "answerText" : {"_value" : "

Information is provided in the table.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

Annual prescription charge increase per item dispensed, in England, in real terms, 2009 to 2015<\/p><\/td><\/tr>

<\/p><\/td>

2009/10<\/p><\/td>

2010/11<\/p><\/td>

2011/12<\/p><\/td>

2012/13<\/p><\/td>

2013/14<\/p><\/td>

2014/15<\/p><\/td>

2015/16<\/p><\/td><\/tr>

Gross Domestic Product (GDP) deflator: year on year growth (%)<\/p><\/td>

2.6<\/p><\/td>

2.8<\/p><\/td>

1.8<\/p><\/td>

1.7<\/p><\/td>

2.1<\/p><\/td>

1.7<\/p><\/td>

1.4<\/p><\/td><\/tr>

Prescription charge per item dispensed (£)<\/p><\/td>

7.20<\/p><\/td>

7.20<\/p><\/td>

7.40<\/p><\/td>

7.65<\/p><\/td>

7.85<\/p><\/td>

8.05<\/p><\/td>

8.20<\/p><\/td><\/tr>

Increase in prescription charge (%)<\/p><\/td>

-<\/p><\/td>

0.0<\/p><\/td>

2.8<\/p><\/td>

3.4<\/p><\/td>

2.6<\/p><\/td>

2.5<\/p><\/td>

1.9<\/p><\/td><\/tr>

Real increase in prescription charge (%)<\/p><\/td>

-<\/p><\/td>

-2.7<\/p><\/td>

1.0<\/p><\/td>

1.7<\/p><\/td>

0.5<\/p><\/td>

0.8<\/p><\/td>

0.5<\/p>

<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

<\/p>

<\/p>

The GDP deflators for 2014/15 and 2015/16 are based on Office for Budget Responsibility forecasts published in the Economic and Fiscal Outlook<\/em> (March 2015)<\/p>

<\/p>

<\/p>

<\/p>

The cost of a three-month Prescription Pre-payment Certificate (PPC) has been frozen since 2011/12 and the 12-month PPC has been frozen since 2009/10. 90% of items are dispensed free.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-24T17:31:48.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the change in prescription charges has been in real terms in each year since 2009-10.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3952", "label" : {"_value" : "Biography information for Mr Toby Perkins"} } , "tablingMemberConstituency" : {"_value" : "Chesterfield"} , "tablingMemberPrinted" : [{"_value" : "Toby Perkins"} ], "uin" : "228320"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-questionFirstAnswered.=2014-11-10T17%3A29%3A12.8111046Z&answeringDeptId=17&session.=2014%2F15&max-dateTabled=2018-04-19&version=2", "page" : 0, "startIndex" : 1, "totalResults" : 509, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }